Jim Cramer weighs in on two key earnings reports next week from Walgreen and Monsanto. Jim Cramer says although Rite Aid recently reported a big drop in earnings, that's no red flag for Walgreen's report. He adds that despite the fact that the stock has had a run, it can keep going higher. As for Monsanto, Cramer says whether or not you believe in the genetically-modified space, the company allows the world to be fed in a cheaper way and there is an endless demand for its products. He says Monsanto has been a buy every time the stock has been hit and this time, he doesn't believe it will be any different.
More from Video
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.
There is a lot of Apple news to chew on Wednesday.